BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 662185)

  • 1. [Preliminary findings on 2 groups of diabetics with regard to platelet aggregation in relation to retinopathy and ultimate relation to antidiabetic therapy].
    Cavaliere R; Giangrandi E; Innocenti M; Parisi R
    Minerva Med; 1978 Jun; 69(28):1923-8. PubMed ID: 662185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Platelet aggregation in diabetes mellitus in relation to diabetic retinopathy].
    Miralles García JM; Pablo Dávila F; Sánchez Martín S; Alberca Silva I
    Rev Clin Esp; 1980 May; 157(3):183-85. PubMed ID: 7403595
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet aggregation and intraplatelet adenine nucleotides in diabetic retinopathy.
    Nozaki H; Hiramatsu K; Arimori S
    Scand J Clin Lab Invest; 1987 Sep; 47(5):441-5. PubMed ID: 3659822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet aggregation in diabetic retinopathy.
    Khosla PK; Mahabaleshwara M; Tewari HK; Saraya AK
    Indian J Ophthalmol; 1981 Oct; 29(3):277-82. PubMed ID: 7346443
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of treatment on retinal circulation, platelet aggregation and blood viscosity in insulin-dependent and noninsulin-dependent diabetics.
    Uchimura I
    Bull Tokyo Med Dent Univ; 1983 Mar; 30(1):17-24. PubMed ID: 6339093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of cephalexin on thrombocyte function in diabetics and normal persons].
    Peters KM; Reuter HD
    Arzneimittelforschung; 1987 Jul; 37(7):843-6. PubMed ID: 3675681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenetic mechanisms of platelet hyperaggregation in diabetics (author's transl)].
    Amado Señars JA; García-Conde Bru J; Merino Sánchez J; Benet Monforte I
    Sangre (Barc); 1981; 26(4):409-16. PubMed ID: 7027491
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet coagulant activities in diabetes mellitus. Evidence for relationship between platelet coagulant hyperactivity and platelet volume.
    Rao AK; Goldberg RE; Walsh PN
    J Lab Clin Med; 1984 Jan; 103(1):82-92. PubMed ID: 6690642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
    Rizkalla SW; Elgrably F; Tchobroutsky G; Slama G
    Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Platelet aggregation in diabetes mellitus at various stages of development of retinopathy].
    Titova SI; Gincherman EZ
    Probl Endokrinol (Mosk); 1979; 25(4):6-11. PubMed ID: 471973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating platelet aggregates induced by somatostatin in insulin-dependent diabetic subjects.
    Coppola L; Giugliano D; Tirelli A; Misso L; Sgambato S; D'Onofrio F
    Diabete Metab; 1980 Dec; 6(4):245-9. PubMed ID: 6110570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating platelet-leukocyte aggregates: a marker of microvascular injury in diabetic patients.
    Elalamy I; Chakroun T; Gerotziafas GT; Petropoulou A; Robert F; Karroum A; Elgrably F; Samama MM; Hatmi M
    Thromb Res; 2008; 121(6):843-8. PubMed ID: 17825880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative studies on the basal blood levels of contrainsular hormones in diabetics with and without retinopathy].
    Vakov L
    Vutr Boles; 1986; 25(4):72-7. PubMed ID: 3532565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of diabetics with metformin].
    Tikholov K; Kalpazanova N; Peshev P; Kostov M; Kusinikov V
    Vutr Boles; 1980; 19(4):21-4. PubMed ID: 7415155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of the level of plasma beta-thromboglobulin in diabetes].
    Stoltz JF; Voisin P; Drouin P; Pointel JP; Benisti G
    Biomedicine; 1980; 33(6):194-6. PubMed ID: 6163487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered platelet function in diabetes mellitus.
    Colwell JA; Halushka PV; Sarji K; Levine J; Sagel J; Nair RM
    Diabetes; 1976; 25(2 SUPPL):826-31. PubMed ID: 823064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of metformin on arginine-induced glucagon secretion in human diabetes.
    Carpentier J; Luyckx AS; Lefebvre PJ
    Diabete Metab; 1975 Mar; 1():23-8. PubMed ID: 1234063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet aggregation and retinal microangiopathy in diabetes and hypertension.
    Khosla PK; Mahabaleswara M; Tiwari HK; Saraya AK
    Acta Haematol; 1979; 61(3):161-7. PubMed ID: 108893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Platelet retention in diabetic patients. Its relation to microangiopathy].
    Cuesta Muñoz J; Faure Nogueras E; Llena Puy MC; Roche Asensio MJ; Zabala López S; Gutiérrez Martín M
    Rev Clin Esp; 1985 Nov; 177(7):321-5. PubMed ID: 4081210
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of beraprost sodium, a stable prostaglandin I2 analogue, on platelet aggregation in diabetes mellitus.
    Kato H; Takashima T; Kishikawa H; Emura S; Ohmori K
    Int J Clin Pharmacol Res; 1996; 16(4-5):99-102. PubMed ID: 9172007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.